Westminster Pharmaceuticals recall thyroid tablets nationwide

Westminster Pharmaceuticals, LLC has recalled Levothyroxine and Liothyronine Thyroid Tablets at the wholesale level.

The company says the products have been recalled as a precaution.

The products were manufactured using pharmaceutical ingredients that were sourced before the FDA’s Import Alert of Sichuan Friendly Pharmaceutical Co., which as a result of a 2017 inspection were found to have deficiencies with Current Good Manufacturing Practices.

Westminster Pharmaceuticals has not received any reports of adverse events related to this product.

According to the Food and Drug Administration, Levothyroxine and Liothyronine tablets (thyroid tablets, USP) are used as a replacement or supplemental therapy in patients with hypothyroidism.

The FDA says these products may be used in the treatment of serious medical conditions, therefore, patients taking the recalled medicine should continue taking their medicine until they have a replacement product.

The products recalled are packed in 100-count bottles.

You can find the NDC’s, Product Description, Lot numbers and Expiration dates of all recalled products here.

These lots were distributed nationwide.

The company is notifying direct accounts by email and phone to immediately discontinue distribution of the product. 

The FDA says instructions for returning recalled products are given in the Recall Notice Letter and Recall Response Form. Consumers that have these products which are being recalled should not discontinue use before contacting their physician for further guidance.

Customers and patients with medical-related questions, information about an adverse event or other questions about the Westminster’s product’s being recalled should contact Westminster’s Regulatory Affairs department by phone 888-354-9939.